SEARCH  web site
COMPANIES
Discover the reality of companies and brands !
List by name, country, industry, manager, or updated this month, by topic:
WHO ARE WE? - HELP - BOOKSTORE
CONTACT T&C BY EMAIL OR WITH SKYPE Skype Me™!
SHOP LOCAL, ETHICAL AND AT THE BEST PRICE WITH Ethishop
 
 en español  en français  in italiano
translate in arabic chinese dutch german japanese korean russian

Home (12954 companies) > France (2162 companies) > Pharmaceuticals (35 companies) >



Aventis SA


Headquarters location: Espace Européen de l'Entreprise 67300 SchiltigheimFranceTel. 03 88 99 15 79 Job offers, investor relations: www.aventis.com Email: jacques.mazard@aventis.com Stock: AVE


Aventis belongs to

shareholder
country     %
source
Sanofi-AventisFrance100

Aventis owns

subsidiary
country     %
source
Aventis Pasteur United States of America100
Centeon LLC United States of America100
Dystar AG Germany35Les Echos
Gallus Gmbh Germany100
Genfit France Les Echos
Rhône Poulenc SA. France100

Brands

name
items photo compare the prices
ActonelSee the photo of: ActonelEthishop
AllegraSee the photo of: AllegraEthishop
AmarylSee the photo of: AmarylEthishop
AravaSee the photo of: AravaEthishop
Aventis See the photo of: AventisEthishop
Biochimica OposSee the photo of: Biochimica OposEthishop
CamptoSee the photo of: CamptoEthishop
CardizemSee the photo of: CardizemEthishop
CefaclorSee the photo of: CefaclorEthishop
ClaforanSee the photo of: ClaforanEthishop
ClexaneSee the photo of: ClexaneEthishop
CopaxoneSee the photo of: CopaxoneEthishop
Dade BehringSee the photo of: Dade BehringEthishop
DelixSee the photo of: DelixEthishop
Dermik PharmaceuticalsSee the photo of: Dermik PharmaceuticalsEthishop
InsumanSee the photo of: InsumanEthishop
KetekSee the photo of: KetekEthishop
LasixSee the photo of: LasixEthishop
LovenoxSee the photo of: LovenoxEthishop
MaxforceSee the photo of: MaxforceEthishop
MerialSee the photo of: MerialEthishop
NasacortSee the photo of: NasacortEthishop
OptinateSee the photo of: OptinateEthishop
RefludanSee the photo of: RefludanEthishop
RilutekSee the photo of: RilutekEthishop
Roussel-UclafSee the photo of: Roussel-UclafEthishop
RPGSee the photo of: RPGEthishop
RulidSee the photo of: RulidEthishop
SOREPHALSee the photo of: SOREPHALEthishop
SynercidSee the photo of: SynercidEthishop
TargocidSee the photo of: TargocidEthishop
TavanicSee the photo of: TavanicEthishop
TaxotereSee the photo of: TaxotereEthishop
TrentalSee the photo of: TrentalEthishop
TritaceSee the photo of: TritaceEthishop
Shop local, ethical and at the best price on Ethishop !

« ETHICAL » RATING OF AVENTIS , group Sanofi-Aventis and subsidiaries [?]
4%
Job: 4% of company's jobs cut since 1998
4
Environment: 4 major pollution(s)
12
Delinquency: 12 act(s) of financial or trade delinquency
3
Tax haven, secret bank account, shell companies: operates in 3 offshore financial center(s)
25
Sales: more than 25 billion(s) dollars/euros in annual sales
4
Net profit: more than 4 billion(s) dollars/euros in cumulated net profit since 1998
806
Top management: earns 806 times the median income in the United States (32000 US$/year)
10
Influence: 10 act(s) of direct corruption or lobbying
3
Advertising & marketing: 3 dubious practice(s)

World locations & Manufacturing

country incentive : address & contact : production type
source
Anthony : R&D Les Echos
Evry : R&D Les Echos
Vitry-sur-Seine : R&D Les Echos
Germany  Francfort : R&D Les Echos
Bermuda Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Carderm Capital LP : Wall Street .
China  Hangzhou : Regent, rovral Les Echos
United States of America  Bridgewater, New Jersey : R&D Les Echos
Ireland Offshore finance, secret bank account, tax haven, shell companies or free zone(s) Waterford : R&D Les Echos
Mexico  Ministère de.

Aventis is managed by

year name
photo position; compensation
source
2004Langlois, Patrick
See the photo of: Langlois, Patrick Chief Financial Officer;
2002Douglas, Frank L
See the photo of: Douglas, Frank L Executive committee;
2002Landau, Igor
See the photo of: Landau, Igor Chairman of the Executive committee; salary: 2 million Eu€; stock-options: 8 million Eu€;
2002Langlois, Patrick
See the photo of: Langlois, Patrick Vice-president;
2002Markham, Richard
See the photo of: Markham, Richard Vice-president;
2002Meier, Heinz-Werner
See the photo of: Meier, Heinz-Werner Executive committee;
2002Oldenburg, Dirk
See the photo of: Oldenburg, Dirk Executive committee;
2002Soursac, Thierry
See the photo of: Soursac, Thierry Executive committee;
2001Dormann, Jurgen
See the photo of: Dormann, Jurgen Chairman of the Executive committee; salary: 2.35 million Eu€; stock-options: 14.87 million Eu€;
2000Fourtou, Jean-René
See the photo of: Fourtou, Jean-René Vice-president;
1999Bruel, Jean-Marc
See the photo of: Bruel, Jean-Marc Monitoring Committee;
1999Dormann, Jurgen
See the photo of: Dormann, Jurgen Chairman of the Executive committee; stock-options: 0.35 million shares;
1999Fruhauf, Martin
See the photo of: Fruhauf, Martin Monitoring Committee;
1999Kampf, Serge
See the photo of: Kampf, Serge Monitoring Committee;
1999Markl, Hubert
See the photo of: Markl, Hubert Monitoring Committee;
1999Metz, Gunter
See the photo of: Metz, Gunter Monitoring Committee;
1999Pineau-Valencienne, Didier
See the photo of: Pineau-Valencienne, Didier Monitoring Committee;
1999Razzouqi, Seham
See the photo of: Razzouqi, Seham Monitoring Committee;
1999Renault, Michel
See the photo of: Renault, Michel Monitoring Committee;
1999Schinzler, Hans-Jurgen
See the photo of: Schinzler, Hans-Jurgen Monitoring Committee;
1999Viénot, Marc
See the photo of: Viénot, Marc Monitoring Committee;
1999Waech, Horst
See the photo of: Waech, Horst Executive committee;

Advertising & marketing

year
dubious practice : image
source
2002Arguable partnership: Institut de France (Académie française, Académie des inscriptions et belles-lettres, Académie des sciences, Académie des beaux-arts, Académie des sciences morales et politiques): "Science Génération":
2001ad budget: 167 million US$; Advertisin.
2000ad budget: 104 million US$; Advertisin.
2000Arguable partnership: Global Compact with the United Nations: value: Respects human, social and environmental laws;
1999 value: Respect de la nature; slogan: Notre challenge, c'est la vie.;

Made by

year
employees
<>
social impact : country
source
2003
-666
AFP
2002
91729
2002
-545
Les Echos
2000
-2200
Les Echos

Environmental impact

year
country : consequences
source
2000 : Production, purchase or sale of genetically modified organisms which may cause an irreversible genetic pollution, a destruction of the biodiversity and health risks for the consumers.

Influence

year
purpose : intermediary/lobby : institution
source
2002Market admission for genetically modified organisms : Europabio : : European Commission translateCorporate .
2000Prevent binding environmental regulations (environmental protection through economic growth, self-regulation and free trade) : WBCSD (World Business Council for Sustainable Development) : : United Nations translateCorporate .
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington.
2000Market access (through WTO), cheaper energy (through energy liberalization in Europe); uniform rules to enable the patenting of plants and animals (through TRIPS); prevent advert legislation on chemicals, self-regulation instead; : CEFIC (European Chemical Industry Council) : : European Commission translateCorporate .
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA
2000Access to public services (privatization through GATS) : ERT (European Roundtable of Industrialists) : : European Commission translateCorporate .

Financials

yearfinancial misdemeanorsalesincome buybacksource
2007 The laboratories Roche, BASF and Aventis were fined 8,5 million dollars in Brazil. They were accused of having formed a cartel, price agreements, market sharing and unfair competition on the market of vitamins. During second half of the Nineties, these three companies would have restricted the offer and increased the prices of the vitamins A, B2, B5 and C They would have also prevented the entry on the market of less expensive Chinese vitamins.    
2006 Roche Holdings AG, BASF AG and Aventis will pay 30.5 mln usd to settle an Australian class action alleging they organised a cartel to fix the price of vitamins. The applicants in the class action, many of whom were farmers, alleged that as a result of the cartel they lost market share or paid inflated prices.     AFX
2005 Sued by the State of California for defrauding the state's $34 billion Medi-Cal program by inflating prices. "We're going to drag these drug companies into courts of law because they've been gouging the public," California Attorney General Bill Lockyer said at a news conference. For example, Medi-Cal paid $804.70 US for a bottle of the hypertension drug Atenolol. Providers such as doctors, clinics and pharmacists paid $33.85 US. As a result, providers reimbursed by Medi-Cal for Atenolol pocketed $770.85 US. The windfalls gave doctors, pharmacies and other providers an incentive to prescribe such drugs, which resulted in even more sales by drug makers, Lockyer said.     Canadian P.
2003   1.9   billion Eu€
2003   1billion Eu€Washington.
2003 Entente sur le prix de la methionine sur le marché états-unien. Aventis verse 178 M$ pour mettre fin aux poursuites.    
2003 Entente illicite; accord entre Aventis et Andrx pour qu'Andrx ne vende pas son médicament pour le coeur Cardizem à un prix inférieur à celui d'Aventis: amende de 80 et 110 millions de $US.    
2002   21.662.28   billion US$
2002 Entente pour fixer le prix de la méthylglucamine entre 1990 et 1999: amende de 2,85 millions d'euros après réduction de 40% pour avoir collaboré lors de l'enquête.     Les Echos
2002 Accused with fraud and bribery schemes to inflate prices for consumers and government health plans.     Financial .
2002 market-sharing and price-fixing cartels affecting vitamin products in Europe: 5,04 million euros fine.     Commission.
2002 Entente sur le prix de la méthionine, échappe à l'amende pour avoir révélé cette entente.     Les Echos
2001   20.451.46   billion US$
2000   22.31.13   billion Eu€
1999   12.6-0.97   billion Eu€

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >


Further investigation
Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal
: present the company activities, improve the ethical rating's accuracy, develop an network of observers.
Name (or ninckname)*
Email
Title*
Link to document online
Information*
Alert me of answers by email * required field
Please copy the antispam code:


The 5 latest validated comments

Subscribe - Log in - Log out |
| © T&C 1999-2008